Cui J, Shen Y, Li R. Estrogen synthesis and signaling pathways during aging: from periphery to brain. Trends Mol Med. 2013;19(3):197–209. https://doi.org/10.1016/j.molmed.2012.12.007.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Iorga A, Cunningham CM, Moazeni S, Ruffenach G, Umar S, Eghbali M. The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy. Biol Sex Differ. 2017;8(1):33. https://doi.org/10.1186/s13293-017-0152-8.PMID:29065927;PMCID:PMC5655818.

Article  PubMed  PubMed Central  Google Scholar 

Nazmeen A, Maiti S, Mandal K, et al. Better predictive value of cancer antigen125 (CA125) as biomarker in ovary and breast tumors and its correlation with the histopathological type/grade of the disease. Med Chem. 2017;13(8):796–804. https://doi.org/10.2174/157340641366617042415545.

Article  CAS  PubMed  Google Scholar 

Nazmeen A, Maiti S. Oxidant stress induction and signalling in xenografted (human breast cancer-tissues) plus estradiol treated or N-ethyl-N-nitrosourea treated female rats via altered estrogen sulfotransferase (rSULT1E1) expressions and SOD1/catalase regulations. Mol Biol Rep. 2018;45(6):2571–84. https://doi.org/10.1007/s11033-018-4425-z.

Article  CAS  PubMed  Google Scholar 

Song B, Wang C, Liu J, et al. MicroRNA-21 regulates breast cancer invasion partly by targeting tissue inhibitor of metalloproteinase 3 expression. J Exp Clin Cancer Res. 2010;29(1):29. https://doi.org/10.1186/1756-9966-29-29.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gialeli C, Theocharis AD, Karamanos NK. Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting. FEBS J. 2011;278(1):16–27 ([PubMed: 21087457]).

Article  CAS  PubMed  Google Scholar 

Maiti S, Nazmeen A. Impaired redox regulation of estrogen metabolizing proteins is important determinant of human breast cancers. Cancer Cell Int. 2019;19:111. https://doi.org/10.1186/s12935-019-0826-x.

Article  PubMed  PubMed Central  Google Scholar 

Sosa V, Moliné T, Somoza R, et al. Oxidative stress and cancer: an overview. Age Res Rev. 2013;12:376–90.

Article  CAS  Google Scholar 

Nazmeen A, Chen G, Ghosh TK, Maiti S. Breast cancer pathogenesis is linked to the intra-tumoral estrogen sulfotransferase (hSULT1E1) expressions regulated by cellular redox dependent Nrf-2/NFκβ interplay. Cancer Cell Int. 2020;4(20):70.

Article  Google Scholar 

Guillam MT, Burcelin R, Thorens B. Normal hepatic glucose production in the absence of GLUT2 reveals an alternative pathway for glucose release from hepatocytes. Proc Natl Acad Sci USA. 1998;95(21):12317–21. https://doi.org/10.1073/pnas.95.21.12317. (PMID:9770484;PMCID:PMC22829).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bhattacharya S, Khan MM, Ghosh C, Bank S, Maiti S. The role of dermcidin isoform-2 in the occurrence and severity of Diabetes. Sci Rep. 2017;7(1):8252. https://doi.org/10.1038/s41598-017-07958-3.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jensen LJ, Kuhn M, Stark M, Chaffron S, Creevey C, Muller J, Doerks T, et al. STRING 8–a global view on proteins and their functional interactions in 630 organisms. Nucleic Acids Res. 2009;37:412–6.

Article  Google Scholar 

Zhao L, Niu H, Liu Y, Wang L, Zhang N, Zhang G, Liu R, Han M. LOX inhibition downregulates MMP-2 and MMP-9 in gastric cancer tissues and cells. J Cancer. 2019;10(26):6481–90. https://doi.org/10.7150/jca.33223.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Karmakar D, Maity J, Mondal P, Shyam Chowdhury P, Sikdar N, Karmakar P, Das C, Sengupta S. E2F5 promotes prostate cancer cell migration and invasion through regulation of TFPI2, MMP-2 and MMP-9. Carcinogenesis. 2020;9:bgaa043. https://doi.org/10.1093/carcin/bgaa043.

Article  CAS  Google Scholar 

Taboada B, Verde C, Merino E. High accuracy operon prediction method based on STRING database scores. Nucleic Acids Res. 2010;38:130.

Article  Google Scholar 

Von Mering C, Jensen LJ, Snel B, Hooper SD, Krupp M, Foglierini M, et al. STRING: known and predicted protein-protein associations, integrated and transferred across organisms. Nucleic Acids Res. 2005;33(Suppl 1):D433-437.

Google Scholar 

Chia CY, Kumari U, Casey PJ. Breast cancer cell invasion mediated by Gα12 signaling involves expression of interleukins-6 and -8, and matrix metalloproteinase-2. J Mol Signal. 2014;9:6.

Article  PubMed  PubMed Central  Google Scholar 

Stoeltzing O, Ahmad SA, Liu W, McCarty MF, Wey JS, Parikh AA, Fan F, Reinmuth N, Kawaguchi M, Bucana CD, et al. Angiopoietin-1 inhibits vascular permeability, angiogenesis, and growth of hepatic colon cancer tumors. Cancer Res. 2003;63:3370–7.

CAS  PubMed  Google Scholar 

Zhang W, Wang F, Xu P, Miao C, Zeng X, Cui X, Lu C, Xie H, Yin H, Chen F, et al. Perfluorooctanoic acid stimulates breast cancer cells invasion and up-regulates matrix metalloproteinase-2/-9 expression mediated by activating NF-κB. Toxicol Lett. 2014;229:118–25.

Article  CAS  PubMed  Google Scholar 

Duffy MJ, Maguire TM, Hill A, McDermott E, O’Higgins N. Metalloproteinases: role in breast carcinogenesis, invasion and metastasis. Breast Cancer Res. 2000;2(4):252–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Klein T, Bischoff R. Physiology and pathophysiology of matrix metalloproteases. Amino Acids. 2010. https://doi.org/10.1007/s00726-010-0689-x.

Article  PubMed  PubMed Central  Google Scholar 

Levi E, Fridman R, Miao HQ, Ma YS, Yayon A, Vlodavsky I. Matrix metalloproteinase 2 releases active soluble ectodomain of fibroblast growth factor receptor 1. Proc Natl Acad Sci USA. 1996;93(14):7069–74.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nilsson UW, Garvin S, Dabrosin C. MMP-2 and MMP-9 activity is regulated by estradiol and tamoxifen in cultured human breast cancer cells. Breast Cancer Res Treat. 2007;102(3):253–61.

Article  CAS  PubMed  Google Scholar 

Philips N, McFadden K. Inhibition of transforming growth factor-beta and matrix metalloproteinases by estrogen and prolactin in breast cancer cells. Cancer Lett. 2004;206(1):63–8.

Article  CAS  PubMed  Google Scholar 

Bernstein L, Ross RK. Endogenous hormones and breast cancer risk. Epidemiol Rev. 1993;15(1):48–65.

Article  CAS  PubMed  Google Scholar 

Maiti S, Zhang J. Chen G Redox regulation of human estrogen sulfotransferase (hSULT1E1). Biochem Pharmacol. 2007;73(9):1474–81.

Article  CAS  PubMed  Google Scholar 

Hudelist G, Wülfing P, Kersting C, Burger H, Mattsson B, Czerwenka K, Kubista E, Gschwantler-Kaulich D, Fink-Retter A, Singer CF. Expression of aromatase and estrogen sulfotransferase in preinvasive and invasive breast cancer. J Cancer Res Clin Oncol. 2008;134(1):67–73.

Article  CAS  PubMed  Google Scholar 

Abdallah MA, Abdullah HI, Kang S, Taylor DD, Nakajima ST, Gercel-Taylor C. Effects of the components of hormone therapy on matrix metalloproteinases in breast-cancer cells: an in vitro study. Fertil Steril. 2007;87(4):978–81.

Article  CAS  PubMed  Google Scholar 

Katayama H, Paczesny S, Prentice R, Aragaki A, Faca VM, Pitteri SJ, Zhang Q, Wang H, Silva M, Kennedy J, Rossouw J, Jackson R, Hsia J, Chlebowski R, Manson J, Hanash S. Application of serum proteomics to the Women’s Health Initiative conjugated equine estrogens trial reveals a multitude of effects relevant to clinical findings. Genome Med. 2009;1(4):47.

Article  PubMed  PubMed Central  Google Scholar 

Pitteri SJ, Hanash SM, Aragaki A, Amon LM, Chen L, BusaldBuson T, Paczesny S, Katayama H, Wang H, Johnson MM, Zhang Q, McIntosh M, Wang P, Kooperberg C, Rossouw JE, Jackson RD, Manson JE, Hsia J, Liu S, Martin L, Prentice RL. Postmenopausal estrogen and progestin effects on the serum proteome. Genome Med. 2009;1(12):121.